VITASOY INT'L (00345) repurchased 50,000 shares for HK$327,900 on September 29.
VITASOY INT'L (00345) announced that the company repurchased 50,000 shares on September 29, 2026, for HK$327,900, at a repurchase price of HK$6.555-6.56 per share.
VITASOY INT'L (00345) announced that the company repurchased 50,000 shares on September 29, 2026, for HK$327,900, at a repurchase price of HK$6.555-6.56 per share.
Related Articles
CSPC PHARMA(01093): The Phase Ib clinical trial of JMT206 injection for weight management in overweight or obese adult patients has officially been initiated at the first research center in China.
EMPEROR CULTURE (00491) Announces Annual Results with Net Profit of HK$1.257 Million, Turning Around from a Loss Year-on-Year
CSPC PHARMA (01093): Recombinant Herpes Zoster Vaccine (SYS 6052) Receives Clinical Trial Approval in the United States
CSPC PHARMA(01093): The Phase Ib clinical trial of JMT206 injection for weight management in overweight or obese adult patients has officially been initiated at the first research center in China.
EMPEROR CULTURE (00491) Announces Annual Results with Net Profit of HK$1.257 Million, Turning Around from a Loss Year-on-Year
CSPC PHARMA (01093): Recombinant Herpes Zoster Vaccine (SYS 6052) Receives Clinical Trial Approval in the United States
